Were the uniQure (QURE) share sales made under a Rule 10b5-1 plan?

Yes. The filing states the reported transactions were effected under a sales plan adopted March 10, 2026, intended to comply with Rule 10b5-1. Such plans pre-schedule trades to reduce discretion over timing.

Does this uniQure (QURE) Form 4 show any gifts or tax-related share withholdings?

No. The transaction summary shows only sales and option exercises. Gift transactions, tax-withholding dispositions, and restructuring entries are all listed as zero in the filing’s aggregated transaction data.

uniQure director exercises options, sells shares

uniQure N.V. director Balachandran Madhavan reported an exercise-and-sell transaction in Ordinary Shares.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

uniQure N.V. director Balachandran Madhavan reported an exercise-and-sell transaction in Ordinary Shares. On June 17, 2026, he exercised stock options for 11,685 shares at strike prices of $19.39 and $31.71 per share.

The same total of 11,685 shares was then sold in open-market transactions at weighted average prices of $42.60, $43.66, and $47.08 per share. The filing states that the sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on March 10, 2026.

Insider Trade Summary 10b5-1

Exercise and Sale: 11,685 shares ($235K approx. pre-tax spread)

Exercise and Sale 7 txns

Insider Balachandran Madhavan

Role Director

Sold 11,685 shs ($526K)

Approx. gross sale proceeds $526K

Approx. exercise cost $292K

Approx. pre-tax spread $235K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	5,295	$0.00	$0.00
Exercise	Stock Option (Right to Buy)	6,390	$0.00	$0.00
Exercise	Ordinary Shares	5,295	$31.71	$168K
Exercise	Ordinary Shares	6,390	$19.39	$124K
Sale	Ordinary Shares	5,295	$47.08	$249K
Sale	Ordinary Shares	4,700	$43.66	$205K
Sale	Ordinary Shares	1,690	$42.60	$72K

Holdings After Transaction: Stock Option (Right to Buy) — 0 contracts (Direct); Ordinary Shares — 43,254 shares (Direct)

Footnotes (6)

F1. The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
F2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.00 to $47.36. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.
F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.12 to $43.95. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.
F4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.50 to $42.93. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.
F5. The Stock Option vested in full on January 25, 2020.
F6. The Stock Option vested in full on January 26, 2019.

Key Figures

Shares sold: 11,685 shares Sale prices: $42.60, $43.66, $47.08/share Options exercised: 11,685 shares +3 more

6 metrics

Shares sold 11,685 shares Total Ordinary Shares sold in open-market transactions on June 17, 2026

Sale prices $42.60, $43.66, $47.08/share Weighted average sale prices for three sale tranches

Options exercised 11,685 shares Total Ordinary Shares acquired via option exercises

Strike prices $19.39 and $31.71/share Exercise prices of two stock option grants

Net share change -11,685 shares Net buy/sell shares per transaction summary (net-sell)

Transaction date June 17, 2026 Date of all reported transactions

Key Terms

Rule 10b5-1, weighted average price, Stock Option (Right to Buy), open-market sale, +1 more

5 terms

Rule 10b5-1 regulatory

"intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Stock Option (Right to Buy) financial

"security_title": "Stock Option (Right to Buy)""

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

derivative exercise/conversion financial

"transaction_action": "derivative exercise/conversion""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did uniQure (QURE) director Balachandran Madhavan report in this Form 4?

He reported exercising options for 11,685 Ordinary Shares and selling the same number in open-market transactions. These trades combined a derivative exercise with immediate share sales at higher market prices.

How many uniQure (QURE) shares did the director sell and at what prices?

He sold 11,685 Ordinary Shares in three open-market transactions. Weighted average sale prices were $42.60, $43.66, and $47.08 per share, each representing groups of trades within stated price ranges.

What stock options did the uniQure (QURE) director exercise in this filing?

He exercised options for 6,390 shares at a $19.39 strike and 5,295 shares at a $31.71 strike. Both option grants had fully vested previously, with expirations in 2028 and 2029, respectively.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/22/2026 - 08:05 AM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Balachandran Madhavan

(Last)

(First)

(Middle)

C/O UNIQURE N.V.

PAASHEUVELWEG 25A

(Street)

AMSTERDAM

1105BP

(City)

(State)

(Zip)

NETHERLANDS

(Country)

2. Issuer Name and Ticker or Trading Symbol
uniQure N.V. [ QURE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	06/17/2026		M⁽¹⁾		5,295	A	$31.71	48,549	D
Ordinary Shares	06/17/2026		M⁽¹⁾		6,390	A	$19.39	54,939	D
Ordinary Shares	06/17/2026		S⁽¹⁾		5,295	D	$47.08⁽²⁾	49,644	D
Ordinary Shares	06/17/2026		S⁽¹⁾		4,700	D	$43.66⁽³⁾	44,944	D
Ordinary Shares	06/17/2026		S⁽¹⁾		1,690	D	$42.6⁽⁴⁾	43,254	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$31.71	06/17/2026		M⁽¹⁾			5,295	⁽⁵⁾	01/25/2029	Ordinary Shares	5,295	$0	0	D
Stock Option (Right to Buy)	$19.39	06/17/2026		M⁽¹⁾			6,390	⁽⁶⁾	01/26/2028	Ordinary Shares	6,390	$0	0	D

Explanation of Responses:

1. The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.00 to $47.36. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.

3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.12 to $43.95. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.

4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.50 to $42.93. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.

5. The Stock Option vested in full on January 25, 2020.

6. The Stock Option vested in full on January 26, 2019.

	/s/ Christian Klemt, Attorney-in-Fact	06/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR